Profile
Ted Llana worked as VP-Oncology & Rheumatology Strategic Business Unit at Biogen, Inc. from 2008 to 2008.
Prior to that, he worked as Vice President at Labcorp Drug Development, Inc., SVP-Commercial & Corporate Development at Abbott Biotherapeutics Corp., and Partner at Documedics.
Dr. Llana holds a doctorate degree from Cornell University and an MBA from Georgetown University.
Former positions of Ted Llana
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/11/2008 |
| COVANCE INC. | Corporate Officer/Principal | - |
Documedics
 Documedics Miscellaneous Commercial ServicesCommercial Services Part of CVS Health Corp., Documedics is a company that provides consulting and reimbursement services of pharmaceutical products. The company is based in San Bruno, CA. Documedics was acquired by US Bioservices Corp., part of CVS Health Corp. from January 17, 2003 on October 24, 2002. | Corporate Officer/Principal | - |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Corporate Officer/Principal | - |
Training of Ted Llana
| Cornell University | Doctorate Degree |
| Georgetown University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Private companies | 3 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Health Technology |
Documedics
Documedics Miscellaneous Commercial ServicesCommercial Services Part of CVS Health Corp., Documedics is a company that provides consulting and reimbursement services of pharmaceutical products. The company is based in San Bruno, CA. Documedics was acquired by US Bioservices Corp., part of CVS Health Corp. from January 17, 2003 on October 24, 2002. | Commercial Services |
- Stock Market
- Insiders
- Ted Llana
